Physician profile
Po Chan
NPI 1225641459
$828.84
in general payments reported to CMS, 2019-2025
12 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $246 · 2023: $31.70 · 2024: $155 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $157.48 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $122.43 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $120.19 | 2022 | |
| Pfizer INC. | $105.98 | 2024 | |
| Amgen INC. | $78.39 | 2025 | Krystexxa |
| Atricure, INC. | $63.35 | 2022 | |
| Csl Behring | $55.27 | 2023-2024 | Kcentra |
| Organogenesis INC. | $37.56 | 2025 | Puraply Wound Matrix |
| Ethicon INC. | $26.29 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $25.45 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.57 | 2022 | |
| Chiesi USA, INC. | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Po Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.